Deutsche Bank downgrades Novo Nordisk to Sell
NVO Novo Nordisk ADR
$47.19 -3.02%
View chart & analysis → - 1Deutsche Bank downgraded Novo Nordisk (NVO) to Sell from Hold
- 2Price target cut 9% to 265 kroner from 290 kroner; Copenhagen shares fell over 3%
- 3Mixed Q2 results, Wegovy pill revenue miss and CagriSema clinical setbacks fueled growth concerns
This 3-line summary is compiled from the report below.
MarketWatch +2 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다